Works matching DE "AMISULPRIDE"

Results: 378

Amisulpride-induced maculopapular rash: a case report.

Published in:

2013

By:

Metin, Handan;
Ozer, Urun;
Ozen, Sakir;
Ozgen, Guliz

Publication type:

Abstract

A New Method for the Determination of Amisulpride in a Small Volume (200 μL) of Human Saliva Using LC-DAD Supported by SPE.

Published in:

Separations (2297-8739), 2023, v. 10, n. 5, p. 277, doi. 10.3390/separations10050277

By:

Dziurkowska, Ewelina;
Kosinska, Sandra;
Plenis, Alina;
Wesolowski, Marek

Publication type:

Article

Polypharmacy in schizophrenia.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2020, v. 126, n. 3, p. 183, doi. 10.1111/bcpt.13384

By:

Baandrup, Lone

Publication type:

Article

Targeting Ca 2+ and Mitochondrial Homeostasis by Antipsychotic Thioridazine in Leukemia Cells.

Published in:

Life (2075-1729), 2022, v. 12, n. 10, p. 1477, doi. 10.3390/life12101477

By:

Moraes, Vivian W. R.;
Santos, Vivian M.;
Suarez, Eloah R.;
Ferraz, Letícia S.;
Lopes, Rayssa de Mello;
Mognol, Giuliana P.;
Campeiro, Joana D.;
Machado-Neto, João A.;
Nascimento, Fabio D.;
Hayashi, Mirian A. F.;
Tersariol, Ivarne L. S.;
Newmeyer, Donald D.;
Rodrigues, Tiago

Publication type:

Article

Traditional Chinese Medicine Decoction Combined With Antipsychotic for Chronic Schizophrenia Treatment: A Systematic Review and Meta-analysis.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.616088

By:

Shi, Xiao-Jie;
Fan, Fang-Cheng;
Liu, Hua;
Ai, Yang-Wen;
Liu, Qing-Shan;
Jiao, Yu-Guo;
Cheng, Yong

Publication type:

Article

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients.

Published in:

2020

By:

Huang, Jing;
Hei, Gang-Rui;
Yang, Ye;
Liu, Chen-Chen;
Xiao, Jing-Mei;
Long, Yu-Jun;
Peng, Xing-Jie;
Yang, Yi;
Zhao, Jing-Ping;
Wu, Ren-Rong

Publication type:

Correction Notice

Early-Onset Schizophrenia With Predominantly Negative Symptoms: A Case Study of a Drug-Naive Female Patient Treated With Cariprazine.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00477

By:

Molnar, Maria Judit;
Jimoh, Idris János;
Zeke, Helga;
Palásti, Ágnes;
Fedor, Marianna

Publication type:

Article

Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond.

Published in:

Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2019.01638

By:

Waddington, John L.;
Zhen, Xuechu;
O'Tuathaigh, Colm M. P.

Publication type:

Article

Metabolism and Excretion of Intravenous, Radio-Labeled Amisulpride in Healthy, Adult Volunteers.

Published in:

Clinical Pharmacology, 2019, v. 11, p. 161, doi. 10.2147/CPAA.S234256

By:

Fox, Gabriel M;
Roffel, Ad F;
Hartstra, Jan;
Bussian, Linda A;
Marle, Sjoerd P van

Publication type:

Article

Treatment-Resistant Schizophrenia, Clozapine Resistance, Genetic Associations, and Implications for Precision Psychiatry: A Scoping Review.

Published in:

Genes, 2023, v. 14, n. 3, p. 689, doi. 10.3390/genes14030689

By:

Ying, Jiangbo;
Chew, Qian Hui;
McIntyre, Roger S.;
Sim, Kang

Publication type:

Article

The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia.

Published in:

Genes, 2022, v. 13, n. 8, p. 1312, doi. 10.3390/genes13081312

By:

Paderina, Diana Z.;
Boiko, Anastasiia S.;
Pozhidaev, Ivan V.;
Mednova, Irina A.;
Goncharova, Anastasia A.;
Bocharova, Anna V.;
Fedorenko, Olga Yu.;
Kornetova, Elena G.;
Semke, Arkadiy V.;
Bokhan, Nikolay A.;
Loonen, Anton J. M.;
Ivanova, Svetlana A.

Publication type:

Article

Occurrence of macroprolactinemia in schizophrenia patients treated with risperidone or amisulpride.

Published in:

Asia-Pacific Psychiatry, 2022, v. 14, n. 1, p. 1, doi. 10.1111/appy.12469

By:

Zhenhua, Wang;
Haizhi, Chen;
Jing, Li;
Xiaocong, Fei;
Jianhua, Li;
Jianjun, Liu;
Lilei, Lei;
Haiying, Jin

Publication type:

Article

Rabbit syndrome as a side effect triggered by amisulpride.

Published in:

2019

By:

Erguner Aral, Ayse;
Ozberk, Berra;
Sarisoy, Gökhan

Publication type:

Case Study

The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8-week, prospective, open-label, multicenter, single-arm study.

Published in:

Asia-Pacific Psychiatry, 2016, v. 8, n. 3, p. 241, doi. 10.1111/appy.12238

By:

Liang, Ying;
Cao, Changan;
Zhu, Cheng;
Wang, Chuanyue;
Zhang, Congpei;
Dong, Fang;
Yang, Fude;
Deng, Hong;
Yu, Jingjie;
Tang, Jisheng;
Su, Lei;
Xin, Limin;
Hong, Ling;
Gao, Minglong;
Tang, Muni;
Xie, Shiping;
Lu, Shuiping;
Liu, Tiebang;
Xu, Xiaojin;
Wang, Xijin

Publication type:

Article

Asymptomatic bradycardia and hypotension associated with amisulpride: A case report.

Published in:

Asia-Pacific Psychiatry, 2016, v. 8, n. 2, p. 175, doi. 10.1111/appy.12226

By:

Su, Chen‐Hsiang;
Chen, Cheng‐Sheng;
Huang, Mei‐Feng

Publication type:

Article

Industry effects on evidence: a case study of long-acting injectable antipsychotics.

Published in:

Accountability in Research: Policies & Quality Assurance, 2024, v. 31, n. 1, p. 2, doi. 10.1080/08989621.2022.2082289

By:

Cosgrove, Lisa;
Mintzes, Barbara;
Bursztajn, Harold J.;
D'Ambrozio, Gianna;
Shaughnessy, Allen F.

Publication type:

Article

The Opioid Interactions of the Antipsychotic Medications Risperidone and Amisulpride in Mice and Their Potential Use in the Treatment of Other Non-Psychotic Medical Conditions.

Published in:

Cellular & Molecular Neurobiology, 2021, v. 41, n. 5, p. 1077, doi. 10.1007/s10571-020-01001-2

By:

Schreiber, Shaul;
Pick, Chaim G.

Publication type:

Article

The adenosine hypothesis of schizophrenia into its third decade: From neurochemical imbalance to early life etiological risks.

Published in:

Frontiers in Cellular Neuroscience, 2023, v. 17, p. 1, doi. 10.3389/fncel.2023.1120532

By:

Singer, Philipp;
Yee, Benjamin K.

Publication type:

Article

The trace amine-associated receptor 1 agonists – non-dopaminergic antipsychotics or covert modulators of D2 receptors?

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 6, p. 503, doi. 10.1177/02698811241249415

By:

Reynolds, Gavin P

Publication type:

Article

Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review.

Published in:

Journal of Psychopharmacology, 2024, v. 38, n. 4, p. 324, doi. 10.1177/02698811241241384

By:

da Rosa, André Luiz Schuh Teixeira;
Bezerra, Olivia Sorato;
Rohde, Luis Augusto;
Graeff-Martins, Ana Soledade

Publication type:

Article

Predicting clozapine dose required to achieve a therapeutic plasma concentration – A comparison of a population algorithm and three algorithms based on gene variant models.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 10, p. 1030, doi. 10.1177/02698811231199104

By:

Taylor, David;
Cahill, Caroline;
Wallang, Paul;
Millard, Louise;
Cela, Luis Ramudo;
Breen, Kieran C

Publication type:

Article

An α7 nAChR approach for the baseline-dependent modulation of deviance detection in schizophrenia: A pilot study assessing the combined effect of CDP-choline and galantamine.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 4, p. 381, doi. 10.1177/02698811231158903

By:

Choueiry, Joëlle;
Blais, Crystal M.;
Shah, Dhrasti;
Smith, Dylan;
Fisher, Derek;
Labelle, Alain;
Knott, Verner

Publication type:

Article

Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports.

Published in:

Journal of Psychopharmacology, 2023, v. 37, n. 2, p. 229, doi. 10.1177/02698811221148611

By:

Hahl-Häkkinen, Lydia;
Rask, Susanna Maria;
Solismaa, Anssi;
Ruuhonen, Sanna;
Leinonen, Esa

Publication type:

Article

Clozapine and the aryl hydrocarbon receptor.

Published in:

Journal of Psychopharmacology, 2022, v. 36, n. 4, p. 516, doi. 10.1177/02698811221085286

By:

Anderson, George

Publication type:

Article

Using a statistical learning approach to identify sociodemographic and clinical predictors of response to clozapine.

Published in:

Journal of Psychopharmacology, 2022, v. 36, n. 4, p. 498, doi. 10.1177/02698811221078746

By:

Fonseca de Freitas, Daniela;
Kadra-Scalzo, Giouliana;
Agbedjro, Deborah;
Francis, Emma;
Ridler, Isobel;
Pritchard, Megan;
Shetty, Hitesh;
Segev, Aviv;
Casetta, Cecilia;
Smart, Sophie E;
Downs, Johnny;
Christensen, Søren Rahn;
Bak, Nikolaj;
Kinon, Bruce J;
Stahl, Daniel;
MacCabe, James H;
Hayes, Richard D

Publication type:

Article

Body mass index as a determinant of clozapine plasma concentrations: A pharmacokinetic-based hypothesis.

Published in:

Journal of Psychopharmacology, 2021, v. 35, n. 3, p. 273, doi. 10.1177/0269881120985166

By:

Kuzin, Maxim;
Haen, Ekkehard;
Hiemke, Christoph;
Bochon, Benjamin;
Bochon, Karolina;
Gründer, Gerhard;
Paulzen, Michael;
Schoretsanitis, Georgios

Publication type:

Article

MicroRNA-195 predicts olanzapine response in drug-free patients with schizophrenia: A prospective cohort study.

Published in:

2021

By:

Huang, Xinxin;
Bao, Chenxi;
Lv, Qinyu;
Zhao, Jing;
Hu, Guoqin;
Wu, Haisu;
Li, Zezhi;
Yi, Zhenghui

Publication type:

journal article

Glyceryl trinitrate in first-episode psychosis unmedicated with antipsychotics: A randomised controlled pilot study.

Published in:

2020

By:

Merritt, Kate;
Catalan, Ana;
Cowley, Samuel;
Demjaha, Arsime;
Taylor, Matthew;
McGuire, Philip;
Cooper, Ruth;
Morrison, Paul

Publication type:

journal article

A prospective multicenter assessor-blinded randomized controlled study to compare the efficacy of short versus long protocols of electroconvulsive therapy as an augmentation strategy to clozapine in patients with ultra-resistant schizophrenia (SURECT study).

Published in:

2021

By:

Moulier, Virginie;
Krir, Mohamed Wassim;
Dalmont, Marine;
SURECT Group;
Bendib, Bilal;
Berjamin, Caroline;
Benosman, Chérifa;
Duhamel, Emeline;
Quesada, Pierre;
Letertre, Benjamin;
Bénichou, Jacques;
Compere, Vincent;
Quiles, Clélia;
Sauvaget, Anne;
Bulteau, Samuel;
Vanelle, Jean-Marie;
Laforgue, Edouard;
Yrondi, Antoine;
Véry, Etienne;
Sporer, Marie

Publication type:

journal article

Profiling of schizophrenia-associated serum peptides by MALDI-TOF-MS.

Published in:

Journal of Neural Transmission, 2020, v. 127, n. 1, p. 95, doi. 10.1007/s00702-019-02108-7

By:

Fu, Yingli;
Zhou, Na;
Yu, Yaqin;
Zhang, Huiping;
Sun, Yaoyao;
Zhang, Mingyuan;
Chen, Xin;
Wang, Yueying;
Yu, Qiong

Publication type:

Article

CSF1R regulates schizophrenia-related stress response and vascular association of microglia/macrophages.

Published in:

BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02959-8

By:

Yan, Ling;
Li, Yanli;
Fan, Fengmei;
Gou, Mengzhuang;
Xuan, Fangling;
Feng, Wei;
Chithanathan, Keerthana;
Li, Wei;
Huang, Junchao;
Li, Hongna;
Chen, Wenjin;
Tian, Baopeng;
Wang, Zhiren;
Tan, Shuping;
Zharkovsky, Alexander;
Hong, L. Elliot;
Tan, Yunlong;
Tian, Li

Publication type:

Article

Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial.

Published in:

BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02968-7

By:

Long, Yujun;
Wu, Qiongqiong;
Yang, Ye;
Cai, Jingda;
Xiao, Jingmei;
Liu, Zhaoqian;
Xu, Yifeng;
Chen, Ying;
Huang, Manli;
Zhang, Ruiguo;
Xu, Xijia;
Hu, Jian;
Liu, Zhifen;
Liu, Fang;
Zheng, Yingjun;
Meng, Huaqing;
Wang, Zhimin;
Tang, Yanqing;
Song, Xueqin;
Chen, Yunchun

Publication type:

Article

Impact of substance use on intestinal permeability in patients with schizophrenia.

Published in:

2024

By:

GARCÍA-FERNÁNDEZ, AINOA;
GONZÁLEZ-BLANCO, LETICIA;
MARTÍNEZ-CAO, CLARA;
PANIAGUA, GONZALO;
COUCE-SÁNCHEZ, MANUEL;
GARCÍA-PORTILLA, MARÍA PAZ;
SÁIZ, PILAR

Publication type:

Letter to the Editor

Malignes neuroleptisches Syndrom durch Amisulprid.

Published in:

Der Nervenarzt, 2008, v. 79, n. 1, p. 86, doi. 10.1007/s00115-007-2343-8

By:

Harter, C.;
Obier, C.;
Druschky, K.-F.;
Eikelmann, B.

Publication type:

Article

Post Hospitalization Clinical Quality Outcomes Among US Patients with Schizophrenia Treated with a Long-Acting Injectable or Switched to a New Oral Antipsychotic: A Retrospective Cohort Study.

Published in:

Drugs - Real World Outcomes, 2024, v. 11, n. 1, p. 69, doi. 10.1007/s40801-023-00408-9

By:

Patel, Charmi;
Emont, Seth;
Cao, Zhun;
Tyagi, Manu;
Benson, Carmela

Publication type:

Article

Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study.

Published in:

Drugs - Real World Outcomes, 2022, v. 9, n. 3, p. 517, doi. 10.1007/s40801-022-00297-4

By:

Janzen, Donica;
Ramkissoon, Reece;
Bolton, James M.;
Leong, Christine;
Kuo, I fan;
Alessi-Severini, Silvia

Publication type:

Article

Virtual twins for model‐informed precision dosing of clozapine in patients with treatment‐resistant schizophrenia.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 3, p. 424, doi. 10.1002/psp4.13093

By:

Mostafa, Sam;
Rafizadeh, Reza;
Polasek, Thomas M.;
Bousman, Chad A.;
Rostami‐Hodjegan, Amin;
Stowe, Robert;
Carrion, Prescilla;
Sheffield, Leslie J.;
Kirkpatrick, Carl M. J.

Publication type:

Article

Activation of Astroglial Connexin Is Involved in Concentration-Dependent Double-Edged Sword Clinical Action of Clozapine.

Published in:

Cells (2073-4409), 2020, v. 9, n. 2, p. 414, doi. 10.3390/cells9020414

By:

Fukuyama, Kouji;
Okubo, Ruri;
Murata, Masahiko;
Shiroyama, Takashi;
Okada, Motohiro

Publication type:

Article

Photocatalytic Degradation of Pharmaceutical Amisulpride Using g-C 3 N 4 Catalyst and UV-A Irradiation.

Published in:

Catalysts (2073-4344), 2023, v. 13, n. 2, p. 226, doi. 10.3390/catal13020226

By:

Antonopoulou, Maria;
Papadaki, Maria;
Rapti, Ilaeira;
Konstantinou, Ioannis

Publication type:

Article

Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone.

Published in:

Clinical Pharmacology in Drug Development, 2022, v. 11, n. 7, p. 865, doi. 10.1002/cpdd.1078

By:

Perlstein, Itay;
Merenlender Wagner, Avia;
Gomeni, Roberto;
Lamson, Michael;
Harary, Eran;
Spiegelstein, Ofer;
Kalmanczhelyi, Attila;
Tiver, Ryan;
Loupe, Pippa;
Levi, Micha;
Elgart, Anna

Publication type:

Article

Cariprazine augmentation of clozapine in schizophrenia—a retrospective chart review.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2023.1321112

By:

Siwek, Marcin;
Chrobak, Adrian Andrzej;
Gorostowicz, Aleksandra;
Król, Patrycja;
Dudek, Dominika

Publication type:

Article

Perioperative utility of amisulpride and dopamine receptor antagonist antiemetics-a narrative review.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1274214

By:

Elias, Murad;
Gombert, Alexa;
Siddiqui, Sulaimaan;
Sun Yu;
Zhaosheng Jin;
Bergese, Sergio

Publication type:

Article

Population pharmacokinetics of Amisulpride in Chinese patients with schizophrenia with external validation: the impact of renal function.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1215065

By:

Anning Li;
Wen Yao Mak;
Tingyi Ruan;
Fang Dong;
Nan Zheng;
Meng Gu;
Wei Guo;
Jingye Zhang;
Haoxuan Cheng;
Canjun Ruan;
Yufei Shi;
Yannan Zang;
Xuequan Zhu;
Qingfeng He;
Xiaoqiang Xiang;
Gang Wang;
Xiao Zhu

Publication type:

Article

Pulmonary Embolism during a Retrial of Low-dose Clozapine.

Published in:

2022

By:

Robbins-Welty, Gregg Alan;
Coats, Shannon;
Tuck, Andrew N.;
Lao, Bryan K.;
Lane, Zachary

Publication type:

Case Study

Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study.

Published in:

Clinical Psychopharmacology & Neuroscience, 2022, v. 20, n. 3, p. 567, doi. 10.9758/cpn.2022.20.3.567

By:

Young Sup Woo;
Sung-Yong Park;
Bo-Hyun Yoon;
Won-Seok Choi;
Sheng-Min Wang;
Won-Myong Bahk

Publication type:

Article

Adherence to Antipsychotic Drugs by Medication Possession Ratio for Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A Retrospective Cohort Study.

Published in:

Clinical Psychopharmacology & Neuroscience, 2022, v. 20, n. 3, p. 491, doi. 10.9758/cpn.2022.20.3.491

By:

Sung Joon Cho;
Jungmee Kim;
Jin Yong Lee;
Jee Hoon Sohn

Publication type:

Article

Clinical Characteristics of Patients with Schizophrenia Maintained without Antipsychotics: A Cross-sectional Survey of a Case Series.

Published in:

Clinical Psychopharmacology & Neuroscience, 2021, v. 19, n. 4, p. 773, doi. 10.9758/cpn.2021.19.4.773

By:

Hideaki Tani;
Masayuki Tomita;
Takefumi Suzuki;
Masaru Mimura;
Hiroyuki Uchida

Publication type:

Article

Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia.

Published in:

Clinical Psychopharmacology & Neuroscience, 2021, v. 19, n. 4, p. 600, doi. 10.9758/cpn.2021.19.4.600

By:

Jung-Jin Kim;
Chi-Un Pae;
Changsu Han;
Won-Myong Bahk;
Soo-Jung Lee;
Patkar, Ashwin A.;
Masand, Prakash S.

Publication type:

Article

Challenges in Prescribing Clozapine in the Era of COVID-19: A Review Focused on Immunological Implications.

Published in:

Clinical Psychopharmacology & Neuroscience, 2021, v. 19, n. 3, p. 411, doi. 10.9758/cpn.2021.19.3.411

By:

Seong Hoon Jeong;
Yong Sik Kim

Publication type:

Article

Positive Symptoms in Antipsychotic-naïve Schizophrenia are Associated with Increased Body Mass Index after Treatment.

Published in:

Clinical Psychopharmacology & Neuroscience, 2021, v. 19, n. 1, p. 155, doi. 10.9758/cpn.2021.19.1.155

By:

Shih-Hsien Lin;
Huai-Hsuan Tseng;
Hsin Chun Tsai;
Mei Hung Chi;
I. Hui Lee;
Po See Chen;
Kao Chin Chen;
Yen Kuang Yang

Publication type:

Article